Pharmafile Logo
Pharmafocus logo
Advanced Search

donidalorsen

Showing 1 posts of 1 posts found.

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026
Research and Development donidalorsen

Otsuka Pharmaceuticals UK announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Dawnzera (donidalorsen) for routine prevention …

News
The Gateway to Local Adoption Series

Latest content

Care Quality Commission appoints Emily Miles as Chief Executive

July 17, 2026

National survey aims to improve glaucoma care across the UK

July 16, 2026

Phase 3 trials support expanded use of Dysport for migraine prevention

July 15, 2026

Roche secures CE Mark for automated latent tuberculosis blood test

July 14, 2026

ReproNovo Phase 2 fertility study doses first participant

July 10, 2026